US Patent Issued to Abbott Diabetes Care on Sept. 1 for "Method and system for providing basal profile modification in analyte monitoring and management systems" (California Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,725,702, issued on Sept. 1, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Method and system for providing basal profile modification in analyte monitoring and management systems" was invented by Mark Kent Sloan (Redwood City, Calif.) and Gary Alan Hayter (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated in...